THE IMPACT OF UNDER KNEE PROSTHESIS ON VARIOUS DIMENSIONS OF LIFE QUALITY OF DISABLED INDIVIDUALS REFERRING TO REHABILITATION CENTER OF SHIRAZ RED CRESCENT IN 2017

Abstract

Objectives: Mutilation is one of the most common motor disability and each year due to factors such as illness, trauma and birth defects about 200 to 500 million mutilation occurs that from this number almost 85% is related to lower limb. Lower limb mutilation creates many changes in the life quality of patients and their families. This study is semi-experimental before and after intervention which has been performed in 2017.

Methods: The research sample is 78 disabled individual of lower limb mutilation referring to rehabilitation center of Shiraz Red Crescent selected with census method. For evaluating variables, TAPES questionnaire has been used. Data analysis was performed with SPSS software and using descriptive and inferential statistics.

Results: Using under knee prosthesis has a significant impact on adaptation scales (the individual adaptation rate with mutilation and using prosthesis) and satisfaction (the individual satisfaction rate from various aspects of prosthesis) but the under knee prosthesis on limitation scale doesn’t have a significant impact. Using under knee prosthesis has had a significant impact on two scales of adaptation and satisfaction of disables and has increased their life quality.

Conclusion: Despite using prosthesis, still there are limitations and dissatisfactions due to sport activities and also high weight of prosthesis for disabled individuals that this problem could be somewhat solved using carbonic prostheses and sport claws. This point should be mentioned that due to the high price of prostheses, most disabled individuals don’t have the possibility of using these services and necessity of being under insurance coverage of these costs for providing more facilities for disabled people is felt more than before.

Peer Review History:

Received 5 December 2017;   Revised 12 January 2018; Accepted 14 February; Available online 15 March 2018

Received file:        Reviewer's Comments: 

Average Peer review marks at initial stage: 6.0/10

Average Peer review marks at publication stage: 8.0/10

Reviewer(s) detail:

Prof. Dr. Kaijian Hou, Endocrine Department, Longhu, First Affiliated Hospital of Shantou University, Shantou city, PR China, kaijianhou@126.com

Prof Dr. Ahmed Kadry Ibrahim Ibrahim Hassan, Atos pharma-Seke, Egypt, kadry_ibrahim173@yahoo.com